TYLENOL PM
- Product NDC
- 50580-833
- 11-digit product format
- 505800833
- Labeler code
- 50580
- Product ID
- 50580-833_5def488c-5857-81d7-e063-6294a90ac270
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Diphenhydramine Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-06-25
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 1000; 50 mg/30mL; mg/30mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 50580-833-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 50580-833-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 50580-833-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 50580-833-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 50580-833-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 50580-833-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 50580-833-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 50580-833-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 50580-833-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 50580-833-01 | ad56d346431e… | cc804d4bbf1e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYLENOL PM
- Brand name suffix
- Extra Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 1000 mg/30mL |
| DIPHENHYDRAMINE HYDROCHLORIDE | 50 mg/30mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44e8a92a-748b-4dc3-ae8d-176a350ac83d | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-02-01 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
| 2024-01-30 | TYLENOL PM Extra Strength |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-833-01 | ML - Milliliter | 50580-833 | 4eb50548-bfd6-4ca0-8b96-8e53a76d98be | 1 | 2018-10-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Low Dose Chewable Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 7d88f156-d361-4249-b70d-4bbcd5ba30b7 | 2025-12-11 | Warnings | M013 |
| Enteric Coated Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | cc18e8e1-652e-44da-a9d7-e56cebda55a1 | 2025-12-11 | Warnings | M013 |
| Extra Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | d4c32e70-778a-4d66-b9d0-03944a528421 | 2025-12-11 | Warnings | M013 |
| adult low dose aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 6fa1c707-bd42-455b-90a3-2c2a11acc683 | 2025-12-11 | Warnings | M013 |
| Extra Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | 5a80cb17-7731-4457-acd3-64cf4accf862 | 2025-12-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | 02e3798f-86d9-64b4-e063-6294a90a29de | 2025-12-11 | Warnings | M013 |
| Regular Strength Pain Relief | ACETAMINOPHEN | VALU MERCHANDISERS COMPANY | f7e87eac-59fb-4a72-b5c6-02953112be6a | 2025-12-11 | Warnings | M013 |
| Aspirin | ASPIRIN | VALU MERCHANDISERS COMPANY | 049ec1aa-66b3-9273-e063-6294a90a221b | 2025-12-11 | Warnings | M013 |
| Aspirin 325 | ASPIRIN | Walgreen Company | f7a5d612-443c-4701-ad3b-8eb53c87bece | 2025-12-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | 355a094c-bed9-4959-8cf0-619f0e246105 | 2025-12-11 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | fac4e0c6-684f-45a1-99f2-de4de4017cc8 | 2025-12-11 | Warnings | M013 |
| Pain Reliever PM extra strength | ACETAMINOPHEN DIPHENHYDRAMINE HCL | P & L Development, LLC | 90eba2e8-52c3-43f5-ba93-4a520368c7f4 | 2025-12-11 | Warnings | M013 |
| Midol Complete, Travel BASIX | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Lil' Drug Store Products, Inc | d6d47af8-5f8c-4c8c-a8c6-aa214ec23bca | 2025-12-10 | Warnings | M013 |
| Tylenol PM Extra Strength, CVP HEALTH | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Lil' Drug Store Products, Inc. | 643371f2-e330-441e-8932-b3aec4b179d2 | 2025-12-10 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | United Natural Foods, Inc. dba UNFI | 18b79449-5c4c-41ce-9609-80f5efa0375c | 2025-12-09 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 36ad34f4-4e66-f371-e063-6394a90ae76a | 2025-12-09 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | LIDL US LLC | ec543339-20ab-2cba-e053-2995a90ac740 | 2025-12-09 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | CHAIN DRUG MARKETING ASSOCIATION, INC. | c57c10fc-f182-4153-8974-ef359a5f5ac1 | 2025-12-09 | Warnings | M013 |
| Pain Relief PM Extra Strength | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | HEB | f7958347-4e9c-4698-8749-7ca7023ee2ba | 2025-12-09 | Warnings | M013 |
| Menstrual Pain Relief Complete | ACETAMINOPHEN, PYRILAMINE MALEATE, CAFFEINE | Shield Pharmaceuticals Corp | 5efd6c61-74ed-4253-896a-e4a40bd8f25b | 2025-12-09 | Warnings | M013 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-833-01 | 50580083301 | 240 mL in 1 BOTTLE (50580-833-01) | 240 ml | 2018-06-25 | 0000-00-00 | No | No | Current |